Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine as Adjuvant to Ropivacaine for Brachial Plexus Block
NCT05767827Completed
- Sponsor
- Nepal Medical College and Teaching Hospital
- Start
- Feb 2023
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in upper extremity fracture (2 arms), sponsored by Nepal Medical College and Teaching Hospital. Primary endpoints: Duration of analgesia after brachial plexus block at 5 months, Onset of sensory and motor block after brachial plexus block at 5 months and 1 more. Started Feb 2023; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
upper extremity fracture
Beyond the preview
Go deeper on NCT05767827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05767827.